Management & Treatment of Diabetic Retinopathy & Complications Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Diabetic retinopathy is associated with prolonged…

A

hyperglycaemia and other conditions linked to diabetes mellitus such as hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what Diabetic Retinopathy retinovascular changes occurs to arterioles and in which 5 ways does this happen

A

occlusion

basement membrane thickening
endothelial cell damage
RBC aggregation
increased platelet stickiness
WBC adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what Diabetic Retinopathy retinovascular changes occurs to venules and how

A

leakage

loss of pericytes - the structural integrity of the BV wall

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Vision loss in diabetic retinopathy is associated with the sequelae of which of the following 2 conditions…

A

Diabetic macular oedema (DMO)
Proliferative diabetic retinopathy (PDR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

list 4 lifestyle changes a diabetic person should make to prevent DR

A

 Glycaemic control

 Blood pressure control

 Reduce lipid in diet (lipid lowering drugs)

 Diet and exercise

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

grade this image

A

R2 M1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

which type of DMO patient does the Early Treatment Diabetic Retinopathy Study (ETDRS) define as a group that would benefit from focal laser treatment

A

Clinically Significant Macular Oedema (CSMO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are the 3 definitions of CSMO

A

Retinal oedema/thickening located at or within 500ųm of the centre of the macula

Exudates at or within 500ųm of the centre of the macula if associated with thickening (oedema) of the adjacent retina

A zone of thickening (oedema) larger than 1 disc area if located within 1 disc diameter of the centre of the macula

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Exudates absorb gradually after…

A

Laser Tx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Exudates worsen when…

A

systemic lipid is high (ETDRS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Extensive exudate within fovea causes…

A

irreversible damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what treatment is this a sign of

A

Temporal macular grid laser

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what treatment is this a sign of

A

Focal / grid macular laser

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Laser scars can…

A

enlarge and become confluent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Heavy laser causes…

A

atrophy and could cause sight loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what does this image show and what can this cause

A

Heavy macular laser scars

which can cause scarring

17
Q

what are these local PEDs a result of and what type of complication can this cause

A

Heavy macular laser

Any breaks within Bruch’s can cause a CNV membrane as a secondary complication

18
Q

what does DMO stand for

A

diffuse macular oedema

19
Q

what treatment is safe and effective intervention for centre-involving DMO

A

Anti –VEGF

20
Q

Anti –VEGF is superior to…

A

laser alone

21
Q

Mean change in visual acuity depends on?

A

baseline mean visual acuity

22
Q

Mean change in CRT depends on?

A

baseline mean CRT

23
Q

what is the initial fixed – individualised regimen of anti VEGF injections required on average

A

average of 8-4-2 number of injections over 3 years

8 - 1st year
4 - 2nd year
2 - 3rd year

24
Q

Ranibizumab is recommended as an option for treating visual impairment due to diabetic macular oedema only if..

A

the eye has a central retinal thickness of 400μm or more at the start of treatment

25
Q

Aflibercept has been recommended as an option for treating visual impairment due to diabetic macular oedema only if..

A

the eye has a central retinal thickness of 400μm or more at the start of treatment

26
Q

would this eye qualify for intravitreal injections with anti- VEGF?

A

No because the Right CRT = 303μm

must be 400um or over

27
Q

would this eye qualify for intravitreal injections with anti- VEGF

A

Yes because Left CRT = 479μm

must be 400um or over

28
Q

what are the 3 treatment options for Proliferative DR: R3A

A

argon laser treatment (PRP) - scatter laser tx
intravitreal anti-VEGF
vitrectomy

29
Q

what did the Diabetic Retinopathy Study Randomised, prospective clinical trial evaluating PRP reveal

A

> 50% reduction in SVL (severe visual loss)

30
Q

what is shown in this image

A

PRP laser

31
Q

name 3 Adjunct treatments that Intravitreal anti-VEGF is used for

A

pre-vitrectomy
pre-cataract surgery
vitreous haemorrhage

32
Q

what DR grade is this?

Name a clinical sign shown in this image

A

Left R3AM0

new vessels at disc

33
Q

what DR grade is this?

Name 2 clinical signs shown in this image

A

Left R3A

Pre retinal fibrosis and active neovascularisation

34
Q

list 3 reasons why a Vitrectomy will need to be indicated for a person with DR

A

Non-clearing / recurrent vitreous haemorrhage
- Type 1 DM: 3 months
- Type 2 DM: 4-6 months

Tractional retinal detachment threatening macula

Combined tractional & rhegmatogeous retinal detachment

35
Q

within what time scale should a Vitrectomy be carried out for a DR px with Non-clearing / recurrent vitreous haemorrhage who has T1 and T2 diabetes respectively

A

Type 1 DM: 3 months

Type 2 DM: 4-6 months

36
Q

In treated eyes, grade does not predict…

A

visual acuity

visual outcome (acuity): depends on macular health

37
Q

visual outcome (acuity): depends on

A

macular health

38
Q

Visual acuity depends on health of macula, but macular involvement is not…

A

directly linked to DR elsewhere